CMRA (Comera Life Sciences Holdings) Interest Expense: $-0.03 Mil (TTM As of Sep. 2023)


What is Comera Life Sciences Holdings Interest Expense?

Comera Life Sciences Holdings CMRA Interest Expense is $-0.03 Mil as of Sep. 2023.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Comera Life Sciences Holdings's interest expense for the three months ended in Sep. 2023 was $ -0.01 Mil. Its interest expense for the trailing twelve months (TTM) ended in Sep. 2023 was $-0.03 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Comera Life Sciences Holdings's Operating Income for the three months ended in Sep. 2023 was $ -2.16 Mil. Comera Life Sciences Holdings's Interest Expense for the three months ended in Sep. 2023 was $ -0.01 Mil. Comera Life Sciences Holdings did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Comera Life Sciences Holdings  (OTCPK:CMRA) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Comera Life Sciences Holdings's Interest Expense for the three months ended in Sep. 2023 was $-0.01 Mil. Its Operating Income for the three months ended in Sep. 2023 was $-2.16 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Sep. 2023 was $0.00 Mil.

Comera Life Sciences Holdings's Interest Coverage for the quarter that ended in Sep. 2023 is calculated as

Comera Life Sciences Holdings did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Comera Life Sciences Holdings Interest Expense Historical Data

* Premium members only.

The historical data trend for Comera Life Sciences Holdings's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Comera Life Sciences Holdings Interest Expense Chart

Comera Life Sciences Holdings Annual Data
Trend Dec20 Dec21 Dec22
Interest Expense
0.00 0.00 -0.02

Comera Life Sciences Holdings Quarterly Data
Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -0.01 -0.01 -0.01 -0.00 -0.01

Comera Life Sciences Holdings Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.03 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of $-0.03 Mil mean?
Comera Life Sciences Holdings (CMRA) has a Interest Expense of $-0.03 Mil as of Sep. 2023. Interest Expense is the amount a company pays on its long-term debt. View historical data on Comera Life Sciences Holdings and its competitors.
Is Comera Life Sciences Holdings' Interest Expense too high?
Comera Life Sciences Holdings' current Interest Expense is $-0.03 Mil.
How does Comera Life Sciences Holdings' Interest Expense compare to FREQ and BNTC?
Comera Life Sciences Holdings' Interest Expense of $-0.03 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Biotechnology company?
A good Interest Expense depends on the Biotechnology industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Comera Life Sciences Holdings and its competitors. Comera Life Sciences Holdings's current Interest Expense is $-0.03 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Comera Life Sciences Holdings stock overvalued right now?
Comera Life Sciences Holdings (CMRA) has a current Interest Expense of $-0.03 Mil. The current Interest Expense is $-0.03 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Comera Life Sciences Holdings (CMRA), the current Interest Expense is $-0.03 Mil as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Comera Life Sciences Holdings Business Description

Address 12 Gill Street, Suite 4650, Woburn, MA, USA, 01801
Comera Life Sciences Holdings Inc is a pre-clinical biotechnology company dedicated to promoting formulation science and technology to transform essential biologic medicines from intravenous to subcutaneous forms. Comera's internal portfolio of proprietary techniques known as the SQore platform is designed to potentially transform essential biologic medicines from intravenous (IV) to subcutaneous (SQ) forms, and optimize current versions of subcutaneous biologics, and produce biosimilar versions of existing subcutaneous products. It also collaborates with pharmaceutical and biotechnology companies, applying the SQore platform to the Company's partners' biologic medicines to deliver enhanced formulations that facilitate self-injectable care.